Page 100 - SGH PR REPORT - FEBRUARY 2025
P. 100
2/19/25, 11:54 AM SGH and BD Company ink MoU to transform healthcare services
the most effective antibiotics, mitigating the overuse of broad-spectrum antibiotics
and combating antibiotic resistance.
This partnership is expected to benefit more than 2 million patients annually,
allowing the healthcare provider to deliver quicker, more accurate diagnostics and
enhance patient outcomes. The agreement aims to streamline microbiology
diagnostic processes, reducing turnaround times and ensuring timely treatment
for patients. With faster and more precise diagnoses, the collaboration is set to
elevate the overall healthcare experience, providing significant advantages to
both patients and healthcare providers.
Philippe Villard, Senior Director of Commercial Operations, EMEA at BD
Company, noted that, “We are excited to collaborate with Saudi German Health
on this innovative initiative. The rollout of our advanced diagnostic solutions will
significantly benefit healthcare providers by improving diagnostic accuracy and
efficiency. Technologies like MALDI-TOF have demonstrated their effectiveness in
enhancing diagnostic outcomes in other regions, and we believe this collaboration
will yield similar results in the Kingdom of Saudi Arabia.”
Top Picks | EHS and Dell sign MoU to enhance digital infrastructure
https://www.gccbusinessnews.com/sgh-and-bd-company-ink-mou-for-healthcare/ 3/3